Publication Month: Feb 2022 | Report Code: TIPRE00027244 | No. of Pages: 167 | Category: Medical Device | Status: Published
A cornea transplant (keratoplasty) is a surgical treatment that involves removing a portion of the cornea and replacing it with corneal tissue from a donor. The transparent, dome-shaped surface of the eye is known as the cornea. It is a large aspect of the eye's ability to see clearly because it is where light enters the eye. A cornea transplant can enhance the appearance of a damaged or diseased cornea while also restoring vision and reducing pain.
|Market Size Value in||US$ 420.71 Million in 2021|
|Market Size Value by||US$ 640.79 Million by 2028|
|Growth rate||CAGR of 6.2% during 2021 to 2028|
|No. of Pages||167|
|No. of Tables||93|
|No. of Charts & Figures||70|
|Historical data available||Yes|
|Segments covered||Type, Indication, End User|
|Regional scope||North America, Europe, Asia Pacific, Middle East & Africa, South & Central America|
|Country scope||US, Canada, Mexico, UK, Germany, Spain, Italy, France, India, China, Japan, South Korea, Australia, UAE, Saudi Arabia, South Africa, Brazil, Argentina|
|Report coverage||Revenue forecast, company ranking, competitive landscape, growth factors, and trends|
|Free Sample Copy Available|
The growth of the corneal transplantation market is attributed to the increasing incidence of eye diseases, and the rising geriatric population. However, the risks associated with Corneal Transplantation and shortage of donor material hampers the market growth.
The geriatric patient population is growing rapidly worldwide due to a significant rise in the subset of patients older than 80. According to the US Department of Health and Human Services, 54.1 million people were aged 65 and above in 2019 (up from 39.6 million in 2020). The population will reach 80.8 million by 2040 and 94.7 million by 2060. As the number of geriatric people increases, the demands of this group for healthcare services also continue to grow. The aging of an ocular surface and corneal tissues, and the consequent impairment of visual functions lead to severe eye diseases and a significant impact on vision. The conditions that affect these vital parts of the eye place a critical medical and socioeconomic burden on society. Thus, the increase in the population of elderlies is driving the overall growth of the corneal transplant market.
Based on type, the global corneal transplantation market has been segmented into penetrating keratoplasty, Descemet Membrane Endothelial Keratoplasty (DMEK), Descemet Stripping Endothelial Keratoplasty (DSEK), Corneal Limbal Stem Cell Transplant, and others. The penetrating keratoplasty segment held the largest share of the market in 2021 and is anticipated to register the CAGR of 6.4% in the market during the forecast period.
Based on indication, the global corneal transplantation market is segmented into fungal corneal ulcer, Fuchs dystrophy, keratoconus, keratitis, and others. The Fuchs dystrophy segment held the largest share of the market in 2021 and is anticipated to register a CAGR of 6.8% in the market during the forecast period.
Based on end user, the Corneal Transplantations market is segmented hospitals, eye clinics, and ambulatory surgical centers. The hospital segment held the largest share of the market in 2021 and is estimated to register the highest CAGR of 6.1% in the market during the forecast period.
Product launches and approvals are commonly adopted strategies by companies to expand their global footprints and product portfolios. Moreover, the corneal transplantation market players focus on the partnership strategy to expand their clientele, which, in turn, permits them to maintain their brand name across the world.